Award
NIH Reporter #5R01CA278802-04
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$698,501.00
Ceiling
$698,501.00
Awarded
June 09, 2023
Identifier
5R01CA278802-04
Research project funded by NIH/NCI to enhance liver-directed radiotherapy and immune checkpoint blockade using TLR5 pathway modulation for liver metastasis and abscopal tumors.
Description
This project involves research on enhancing liver-directed radiotherapy and immune checkpoint blockade using TLR5 pathway modulation, with a focus on translational relevance in human tumors. The project is funded by the NIH/NCI and involves collaboration with Roswell Park Cancer Institute.